- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
-
- TERAKURA Seitaro
- Department of Hematology, Nagoya University Hospital
-
- ONJI Masaaki
- Department of Hematology, Nagoya University Hospital
-
- IRIYAMA Chisako
- Department of Hematology, Nagoya University Hospital
-
- GOTO Tatsunori
- Department of Hematology, Nagoya University Hospital
-
- USHIJIMA Yoko
- Department of Hematology, Nagoya University Hospital
-
- SHIMADA Kazuyuki
- Department of Hematology, Nagoya University Hospital
-
- ISHIKAWA Yuichi
- Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
- NISHIDA Tetsuya
- Department of Hematology, Nagoya University Hospital
-
- HAYAKAWA Fumihiko
- Department of Hematology, Nagoya University Hospital
-
- MURATA Makoto
- Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
- KIYOI Hitoshi
- Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
Bibliographic Information
- Other Title
-
- 心臓浸潤を認めた悪性リンパ腫
- 症例報告 心臓浸潤を認めた悪性リンパ腫
- ショウレイ ホウコク シンゾウ シンジュン オ ミトメタ アクセイ リンパシュ
Search this article
Description
<p>Malignant lymphoma with cardiac involvement is difficult to diagnose and treatment selection decisions can be challenging, because patients usually present with atypical disease involvement and the incidence is low. Herein, we describe the clinical characteristics and courses of three non-Hodgkin lymphoma patients showing cardiac involvement. All three patients were male, ages 32, 74 and 64 years. All three patients had presented with cardiac involvement mainly in the right heart system. We promptly performed needle biopsies for patients 1 and 3, and open-heart biopsy for patient 2, which showed PMBL for patient 1, DLBCL for patients 2 and 3. Since we were concerned regarding possible transient exacerbation of heart failure or the occurrence of fatal arrhythmia, we chose to start with relatively low dose chemotherapeutic interventions or pre-phase steroid therapy. After one course of chemotherapy or pre-phase steroid therapy, symptoms associated with heart failure almost completely subsided, and we further administered full-dose chemotherapy thereafter, resulting in complete responses in 2 cases. This case series demonstrates that malignant lymphoma with cardiac involvement is a treatable disease, despite widespread involvement. Furthermore, rapid and appropriate diagnostic imaging and biopsy are important when this disease is suspected.</p>
Journal
-
- Rinsho Ketsueki
-
Rinsho Ketsueki 58 (3), 239-242, 2017
The Japanese Society of Hematology
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205034830208
-
- NII Article ID
- 130005549372
-
- NII Book ID
- AN00252940
-
- ISSN
- 18820824
- 04851439
-
- NDL BIB ID
- 028086179
-
- PubMed
- 28381692
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- Abstract License Flag
- Disallowed